Show Notes
In this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Dr. Rick Pescatore, board-certified emergency physician, Editor-in-Chief of Emergency Medicine News, and founder of BellyMD, for a fascinating deep dive into the gut-brain connection and what it means for cannabis users and patients dealing with unexplained digestive symptoms.
Dr. Pescatore explains how the gut and brain communicate through the vagus nerve, why the gut has been called the “second brain,” and how genetics, diet, gut bacteria, inflammation, and cannabis can all influence this complex system. The conversation also explores cannabinoid hyperemesis syndrome (CHS) and why understanding CHS requires looking beyond cannabis alone and considering the broader gut-brain system.
We also get into GLP-1 medications and gut-brain medicine, nausea and vomiting, microbiome health, micronutrient deficiencies, vitamin B1 (thiamine), magnesium, and whether personalized health data could help us better understand why someone feels unwell. Dr. Pescatore shares how emerging tools, including phenomic data, wearable technology, AI, and the Menome platform, could help patients identify patterns that traditional medicine may overlook.
We also discuss cannabis and the gut microbiome, CHS, thiamine deficiency, antibiotics and gut health, personalized medicine, patient autonomy, and the future of gut-brain healthcare.
In this episode, we explore:
- What is the gut-brain axis and how does the gut communicate with the brain?
- Why does the gut have such a major role in neurotransmitters and brain health?
- What does the gut microbiome have to do with anxiety, depression, and other conditions?
- What is cannabinoid hyperemesis syndrome (CHS), and how does it fit into gut-brain health?
- Could underlying gut-brain dysfunction contribute to cannabis-related symptoms?
- How do GLP-1 medications affect the gut-brain axis?
- What role do vitamin B1, magnesium, and micronutrients play in gut-brain health?
- Can microbiome testing and wearable data help personalize healthcare?
- Could AI help patients better understand their own health?
- What does the future of personalized gut-brain medicine look like?
This is a conversation about cannabis, medicine, the microbiome, nutrition, neuroscience, personalized health, and the emerging science connecting them all.
CHAPTERS:
00:00 CHS Big Picture
01:17 Podcast Welcome
02:18 Meet Dr Pescatore
03:50 Defining Gut Brain Axis
05:50 Second Brain Neurons
06:42 Leaky Gut Explained
07:44 Omics And AI Boom
11:18 GLP1s As Gut Brain Drugs
13:57 GLP1 Risks And Nausea
16:46 Supplements And Diet Basics
18:28 Personalized Testing Options
19:57 Menome Phenomic App
23:46 Digital Biomarker Score
24:56 CHS Telemedicine Pipeline
27:32 Scromiting Dopamine Clue
28:28 What Really Causes CHS
29:14 Dopamine Targeted Treatment
30:06 Genetics And Dopamine Links
31:49 Gut Inflammation Hypersensitivity
32:52 Microbiome And Vitamin Deficits
34:29 Probiotics Versus Supplements
35:54 Thiamine Magnesium Protocol
37:33 Side Effects And Vivid Dreams
40:33 Can Patients Use Again
41:48 FMT And Antibiotic Fallout
43:44 Cannabis Heart Risk Reality
45:34 ER Priorities Psychosis CHS
46:25 Prevention Tips And B1 For All
47:25 Social Media And The App
50:10 Patient Autonomy And Wrap Up
Explore Dr. Rick Pescatore & BellyMD
🌐 Rick Pescatore: rickpescatore.com 🌐 BellyMD: belly-md.com 📱 Menome: menome.belly-md.com
Bioactive Podcast listeners can get 3 months of free access to Menome with code MGBSUB1MO.
🌿 MGB+ Calm: BellyMD MGB+ Calm Use code RILEY15 for discount.
Want Exclusive Content and ad-free episodes?
Join the Bioactive Patreon community for as little as $1/month to ask guests your burning
questions, access exclusive content, and connect with Dr. Kirk one-on-one.
www.Patreon.com/Cannabichem
Don’t forget to like, subscribe, and hit the notification bell for more expert insights into
cannabis science, plant biology, a
More from BIOACTIVE
What are cannabis terpenes, how do they influence aroma and consumer experiences, and what do we know about their safety? On this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Dr. Shawna Vreeke, PhD, DABT, Head of Toxicology at True Terpenes, to explore the science of cannabis terpenes, terpene chemistry, cannabinoid interactions, and consumer safety. With a PhD in Chemistry focused on toxin formation in vape device aerosols and expertise in toxicology risk assessment, Shawna shares insights into what current research tells us about terpenes and where important questions remain unanswered.
Dr. Riley Kirk welcomes Dr. Miyabe Shields for a deep dive into cannabis real-world data, cannabis consumption patterns, dosing, neurodivergent cannabis use, and the Endocannabinoid System (ECS). As co-founders of the Network of Applied Pharmacognosy (NAP), Riley and Miyabe discuss the newly accessible Real Data Project, including what large-scale consumer data can reveal about how people actually use cannabis in their everyday lives.
What if carbon is one of the most overlooked inputs in plant nutrition? In this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Nik Nikolayev, CEO of Rooted Leaf Agritech, to explore the science of carbon-based fertilizers, plant nutrition, biostimulants, organic acids, and the chemistry behind plant growth, yield, and quality.
Dr. Riley Kirk has Dr. Denise Valenti on the podcast to discuss cannabis and driving, cannabis impairment, THC testing, and the challenges of determining whether someone is actually too impaired to drive. They explore why THC levels in the body do not necessarily correspond to impairment and how cannabis can affect vision, peripheral vision, contrast sensitivity, eye movement, balance, and pupil response.
What actually happened inside the DEA’s cannabis rescheduling hearing? In this timely episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Max Jackson, former commercial cannabis cultivator and founder of Cannabis Wise Guys, to unpack what he witnessed firsthand at the DEA hearing on moving cannabis from Schedule I to Schedule III.